Bird Rock Bio

OverviewSuggest Edit

Bird Rock Bio is focused on the discovery and development of novel biologic therapeutics that meet the medical and commercial needs for China’s patients and healthcare system and that have the potential to be disruptive globally. RYI-008 is a novel, extremely potent monoclonal antibody that is highly selective to IL-6, a cytokine widely implicated in inflammation and cancer. In addition to RYI-008, RuiYi has a growing pipeline of monoclonal antibodies from its internal discovery efforts utilizing a series of the Company’s technologies, including the iCAP (intramembranous Conformation Antigen Presenting) system. Targets include a select subset of G protein coupled receptors (GPCR), where specificity in binding is critical but has proven difficult to achieve with small molecule modulators.

HQSan Diego, CA, US

Latest Updates

Employees (est.) (Sept 2021)3
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Bird Rock Bio

Paul A. Grayson

Paul A. Grayson

President and Chief Executive Officer
Alan Glicklich

Alan Glicklich

Chief Medical Officer
Anke Kretz-Rommel

Anke Kretz-Rommel

Chief Technology Officer
Shay Tabani

Shay Tabani

Global Head of Quality
Roger Ferrini

Roger Ferrini

Head of Antibody Discovery Technology
Jerlyn Tolentino

Jerlyn Tolentino

Director of Clinical Operations
Show more

Bird Rock Bio Office Locations

Bird Rock Bio has an office in San Diego
San Diego, CA, US (HQ)
2223 Avenida De La Playa #205, La Jolla
Show all (1)

Bird Rock Bio Financials and Metrics

Summary Metrics

Founding Date


Bird Rock Bio total Funding

$71 m

Bird Rock Bio latest funding size

$5 m

Time since last funding

6 years ago

Bird Rock Bio investors

Bird Rock Bio's latest funding round in January 2016 was reported to be $5 m. In total, Bird Rock Bio has raised $71 m
Show all financial metrics

Bird Rock Bio Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Bird Rock Bio Online and Social Media Presence

Embed Graph

Bird Rock Bio Company Culture

  • CEO Rating



  • Compensation



Learn more on Comparably

Bird Rock Bio Blogs

Bird Rock Bio Completes Clinical Trial of Nimacimab in Patients with Fatty Liver Disease

La Jolla, Calif., September 13, 2018 – Bird Rock Bio, Inc., a […]

Bird Rock Bio Frequently Asked Questions

  • When was Bird Rock Bio founded?

    Bird Rock Bio was founded in 2002.

  • Who are Bird Rock Bio key executives?

    Bird Rock Bio's key executives are Paul A. Grayson, Alan Glicklich and Anke Kretz-Rommel.

  • How many employees does Bird Rock Bio have?

    Bird Rock Bio has 3 employees.

  • Who are Bird Rock Bio competitors?

    Competitors of Bird Rock Bio include Cell Signaling Technology, Ginkgo Bioworks and Unither Pharmaceuticals.

  • Where is Bird Rock Bio headquarters?

    Bird Rock Bio headquarters is located at 2223 Avenida De La Playa #205, La Jolla, San Diego.

  • Where are Bird Rock Bio offices?

    Bird Rock Bio has an office in San Diego.

  • How many offices does Bird Rock Bio have?

    Bird Rock Bio has 1 office.